James Gordon

Stock Analyst at JP Morgan

(2.90)

# 1,496

Out of 4,789 analysts

7

Total ratings

80%

Success rate

22.47%

Average return

Main Sectors:

Top Industries:

Stocks Rated by James Gordon

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ARGX argenx SE	Maintains: Overweight	$640 → $670	$591.87	+13.20%	5	Nov 4, 2024
	GMAB Genmab	Downgrades: Neutral	n/a	$19.58	-	1	Aug 20, 2024
	FGEN FibroGen	Upgrades: Neutral	n/a	$0.31	-	1	Apr 7, 2021

argenx SE

Nov 4, 2024

Maintains: Overweight

Price Target: $640 → $670

Current: $591.87

Upside: +13.20%

Genmab

Aug 20, 2024

Downgrades: Neutral

Price Target: n/a

Current: $19.58

Upside: -

FibroGen

Apr 7, 2021

Upgrades: Neutral

Price Target: n/a

Current: $0.31

Upside: -